Differential control of TAp73 and ΔNp73 protein stability by the ring finger ubiquitin ligase PIR2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 29, 2010, Pages 12877-12882

  Sayan, Berna S ^a   Yang, Ai Li ^a   Conforti, Franco ^b   Tucci, Paola ^c   Piro, Maria Cristina ^c   Browne, Gareth J ^a   Agostini, Massimiliano ^a   Bernardini, Sergio ^b   Knight, Richard A ^a   Mak, Tak W ^d   Melino, Gerry ^a,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Princess Margaret Hospital   (Canada)

Author keywords

DNA damage; p73; RNF144b; Ubiquitylation

Indexed keywords

MESSENGER RNA; PROTEIN P53; PROTEIN P73; PROTEIN RING FINGER PIR 2; PROTEIN RING FINGER UBIQUITIN LIGASE P 73; RING FINGER PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; DNA DAMAGE; EMBRYO CELL; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; DNA DAMAGE; DNA-BINDING PROTEINS; HCT116 CELLS; HUMANS; MICE; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RING FINGER DOMAINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MUS;

EID: 77955648341     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911828107     Document Type: Article

References (33)

1. Melino G, Lu X, Gasco M, Crook T, Knight RA (2003) Functional regulation of p73 and p63: Development and cancer. Trends Biochem Sci 28:663-670.
2. Melino G, De Laurenzi V, Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2:605-615.
3. Ishimoto O, et al. (2002) Possible oncogenic potential of DeltaNp73: A newly identified isoform of human p73. Cancer Res 62:636-641.
4. Stiewe T, Theseling CC, Pützer BM (2002) Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: Implications for tumorigenesis. J Biol Chem 277:14177-14185.
5. Pozniak CD, et al. (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289:304-306.
6. Zaika AI, et al. (2002) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196:765-780.
7. Bergamaschi D, et al. (2003) p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3:387-402.
8. Vossio S, et al. (2002) DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Oncogene 21:3796-3803.
9. Pützer BM, Tuve S, Tannapfel A, Stiewe T (2003) Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN′-p73 transcript. Cell Death Differ 10:612-614.
10. Nakagawa T, et al. (2002) Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol 22:2575-2585.
11. Kartasheva NN, Contente A, Lenz-Stöppler C, Roth J, Dobbelstein M (2002) p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene 21:4715-4727.
12. Grob TJ, et al. (2001) Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8:1213-1223.
13. Oberst A, et al. (2007) The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proc Natl Acad Sci USA 104:11280-11285.
14. Mantovani F, et al. (2004) Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 14:625-636.
15. Costanzo A, et al. (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell 9:175-186.
16. Bernassola F, et al. (2004) Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med 199:1545-1557.
17. Kaghad M, et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
18. Gong JG, et al. (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809.
19. Sayan AE, et al. (2008) P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis. Oncogene 27:4363-4372.
20. Maisse C, Munarriz E, Barcaroli D, Melino G, De Laurenzi V (2004) DNA damage induces the rapid and selective degradation of the DeltaNp73 isoform, allowing apoptosis to occur. Cell Death Differ 11:685-687.
21. Müller M, et al. (2005) TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 12:1564-1577.
22. Melino G, et al. (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083.
23. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425-479.
24. Rossi M, et al. (2005) The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 24:836-848. (Pubitemid 40396112)
25. Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G (2009) The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene 35:3157-3166.
26. Asher G, Tsvetkov P, Kahana C, Shaul Y (2005) A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19:316-321.
27. Ng CC, Arakawa H, Fukuda S, Kondoh H, Nakamura Y (2003) p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene 22:4449-4458.
28. Huang J, Xu LG, Liu T, Zhai Z, Shu HB (2006) The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis. FEBS Lett 580:940-947.
29. Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM (2006) p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem 281:13566-13573.
30. Sayan BS, et al. (2007) Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis. Proc Natl Acad Sci USA 104:10871-10876.
31. Sayan AE, et al. (2005) New antibodies recognizing p73: Comparison with commercial antibodies. Biochem Biophys Res Commun 330:186-193.
32. Sayan AE, Sayan BS, Findikli N, Ozturk M (2001) Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells. Oncogene 20:5111-5117.
33. Sayan BS, Ince G, Sayan AE, Ozturk M (2001) NAPO as a novel marker for apoptosis. J Cell Biol 155:719-724.